Stay updated on APR-246 & Azacitidine in TP53 MDS Clinical Trial
Sign up to get notified when there's something new on the APR-246 & Azacitidine in TP53 MDS Clinical Trial page.

Latest updates to the APR-246 & Azacitidine in TP53 MDS Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe ClinicalTrials.gov footer release identifier changed from v3.7.2 to v3.8.0. The study record content remains unchanged.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA notice announces that NIH is transitioning to using “Super Intelligence” in place of “Artificial Intelligence.” The site’s displayed revision changes from v3.7.1 to v3.7.2.SummaryDifference0.7%

- Check39 days agoChange DetectedThe site's displayed revision changed from v3.7.0 to v3.7.1, with the study record history otherwise unchanged.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision entry v3.7.0 was added to the study history. The previous v3.6.6 entry was removed.SummaryDifference0.1%

- Check74 days agoChange DetectedThe Record History now shows a newer revision entry (v3.6.6) replacing the older v3.6.5, indicating a small platform update to the history log.SummaryDifference0.1%

- Check95 days agoChange DetectedThe history now shows a new revision tag, v3.6.5, replacing the previous v3.6.4 in the record history. This reflects an update to the published version of the record rather than changes to its substantive data.SummaryDifference0.1%

Stay in the know with updates to APR-246 & Azacitidine in TP53 MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APR-246 & Azacitidine in TP53 MDS Clinical Trial page.